Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium

Michele Till; Richard L Wixson; Peter E Pertel

doi:10.1086/340265

Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium

Clin Infect Dis. 2002 May 15;34(10):1412-4. doi: 10.1086/340265. Epub 2002 Apr 23.

Authors

Michele Till¹, Richard L Wixson, Peter E Pertel

Affiliation

¹ Division of Infectious Diseases, Department of Medicine, Northwestern University Medical School, Chicago, IL, USA.

PMID: 11981739
DOI: 10.1086/340265

Abstract

The incidence of nosocomial infections caused by vancomycin-resistant enterococci has risen substantially during the past 15 years. We report the use of linezolid for the successful treatment of hip prosthesis infection associated with osteomyelitis due to vancomycin-resistant Enterococcus faecium.

Publication types

Case Reports

MeSH terms

Acetamides / therapeutic use*
Aged
Anti-Bacterial Agents / therapeutic use*
Cross Infection / drug therapy
Cross Infection / microbiology
Enterococcus faecium* / drug effects
Gram-Positive Bacterial Infections / drug therapy*
Humans
Linezolid
Male
Microbial Sensitivity Tests
Osteomyelitis / drug therapy*
Osteomyelitis / microbiology
Oxazolidinones / therapeutic use*
Vancomycin Resistance

Substances

Acetamides
Anti-Bacterial Agents
Oxazolidinones
Linezolid